Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medifast (MED) Change in Receivables (2016 - 2021)

Historic Change in Receivables for Medifast (MED) over the last 12 years, with Q1 2021 value amounting to -$496000.0.

  • Medifast's Change in Receivables rose 5262.66% to -$496000.0 in Q1 2021 from the same period last year, while for Mar 2021 it was $254000.0, marking a year-over-year decrease of 9252.28%. This contributed to the annual value of -$297000.0 for FY2020, which is 10730.81% down from last year.
  • Latest data reveals that Medifast reported Change in Receivables of -$496000.0 as of Q1 2021, which was up 5262.66% from -$15000.0 recorded in Q4 2020.
  • Over the past 5 years, Medifast's Change in Receivables peaked at $3.7 million during Q3 2019, and registered a low of -$1.0 million during Q1 2020.
  • Over the past 5 years, Medifast's median Change in Receivables value was $19000.0 (recorded in 2017), while the average stood at $208411.8.
  • In the last 5 years, Medifast's Change in Receivables soared by 205789.47% in 2018 and then tumbled by 25185.19% in 2019.
  • Quarter analysis of 5 years shows Medifast's Change in Receivables stood at $19000.0 in 2017, then soared by 2057.89% to $410000.0 in 2018, then rose by 1.22% to $415000.0 in 2019, then plummeted by 103.61% to -$15000.0 in 2020, then crashed by 3206.67% to -$496000.0 in 2021.
  • Its Change in Receivables was -$496000.0 in Q1 2021, compared to -$15000.0 in Q4 2020 and $319000.0 in Q3 2020.